Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Torrent Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:500420NSE Symbol: TORNTPHARMP/E(TTM):62.43
ISIN Demat:INE685A01028Div & Yield %:0.15EPS(TTM):63.06
Book Value(Rs):249.8252811Market Cap ( Cr.):133240.89Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 9682.448532.907695.206742.326450.576168.44
Excise Duty0.000.000.000.000.000.00
Net Sales9682.448532.907695.206742.326450.576168.44
Other Income 31.5091.3681.88204.17118.34236.93
Stock Adjustments 9.0468.61-128.4418.34150.1456.83
Total Income9722.988692.877648.646964.836719.056462.20
EXPENDITURE :      
Raw Materials 2249.842200.392010.981925.841819.811694.28
Power & Fuel Cost134.25143.43153.21140.00122.04126.70
Employee Cost 1636.451450.671251.221097.931097.121061.76
Other Manufacturing Expenses 189.02173.82143.39141.56136.19130.43
Selling and Administration Expenses 1396.831254.381138.57954.66851.08918.63
Miscellaneous Expenses 533.53489.52404.23399.91382.74376.48
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure6139.925712.215101.604659.904408.984308.28
Operating Profit3583.062980.662547.042304.932310.072153.92
Interest 213.40303.04297.68236.29334.12430.49
Gross Profit3369.662677.622249.362068.641975.951723.43
Depreciation759.48761.05672.34602.43609.84606.66
Profit Before Tax2610.181916.571577.021466.211366.111116.77
Tax540.56321.67274.20253.27247.77192.13
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax181.56237.82251.43221.49-19.51-13.87
Reported Net Profit1888.061357.081051.39991.451137.85938.51
Extraordinary Items -4.2014.8827.976.8612.7524.18
Adjusted Net Profit1892.261342.201023.42984.591125.10914.33
Adjst. below Net Profit -27.140.44-7.07-1.557.21-120.06
P & L Balance brought forward3736.393394.213212.922899.912093.301884.05
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1082.981015.34863.03676.89338.45609.20
P & L Balance carried down4514.333736.393394.213212.922899.912093.30
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %120.00560.00440.00960.00700.00640.00
Earnings Per Share-Unit Curr55.7840.1031.0658.5867.2355.45
Earnings Per Share(Adj)-Unit Curr55.7840.1031.0629.2933.6227.73
Book Value-Unit Curr224.32201.76190.75374.94356.30302.59